Cargando…

Clinical differences between small and large pheochromocytomas and paragangliomas

BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lin, Li, ZhiMao, Meng, Xu, Fan, Hua, Zhang, ZengLei, Zhang, ZhaoCai, Liu, YeCheng, Zhou, XianLiang, Zhu, HuaDong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034061/
https://www.ncbi.nlm.nih.gov/pubmed/36967797
http://dx.doi.org/10.3389/fendo.2023.1087506
_version_ 1784911126926983168
author Zhao, Lin
Li, ZhiMao
Meng, Xu
Fan, Hua
Zhang, ZengLei
Zhang, ZhaoCai
Liu, YeCheng
Zhou, XianLiang
Zhu, HuaDong
author_facet Zhao, Lin
Li, ZhiMao
Meng, Xu
Fan, Hua
Zhang, ZengLei
Zhang, ZhaoCai
Liu, YeCheng
Zhou, XianLiang
Zhu, HuaDong
author_sort Zhao, Lin
collection PubMed
description BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs is insufficient. METHODS: A retrospective analysis of patients with PPGLs treated at our institution between January 2018 and June 2020 was performed. The clinical characteristics of patients were investigated, and comparisons were made between patients with large and small PPGLs. The logistic regression analysis was used to confirm the risk factors, and the receiver operating characteristic curve was used to evaluate the diagnostic performance of the variables. RESULTS: Totally 263 patients were included, including 110 patients in small tumor group and 153 patients in large tumor group. There were more male patients in the large tumor group (p=0.009). More patients had hypertension (p<0.001) and diabetes (p=0.002) in the large tumor group. The 24-h urinary epinephrine (24hU-E) (p < 0.001) and 24-h urinary norepinephrine (24hU-NE) (p=0.002) concentrations were higher in the large tumor group. In terms of tumor location, adrenal-PPGLs were more frequent in the large tumor group (p<0.001). Multivariate logistic regression analysis showed that male sex [odds ratio (OR): 2.871, 95% confidence interval (CI): 1.444–5.711, p=0.003], 24hU-E concentrations (OR: 1.025, 95% CI:1.004–1.047, p=0.020), 24hU-NE concentrations (OR: 1.002, 95%CI: 1.001–1.004, p=0.045), and adrenal-PPGLs (OR: 2.510, 95% CI:1.256–5.018, p=0.009) were positive risk factors for large tumors. Taking above variables into the same model, the area under the receiver operating characteristic curve of the model for predicting the large tumor was 0.772 (95% CI: 0.706–0.834). After the short-term follow-up, there was no significant difference in tumor recurrence between the two groups (p=0.681). CONCLUSIONS: Significant differences in numerous clinical characteristics exist between large and small PPGLs. The male patients were more likely to be with large tumors, and such tumors were more likely to reside on the adrenal glands. Catecholamine measurements also help predict tumor size of PPGLs. Clinical decision-making will benefit from this information.
format Online
Article
Text
id pubmed-10034061
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100340612023-03-24 Clinical differences between small and large pheochromocytomas and paragangliomas Zhao, Lin Li, ZhiMao Meng, Xu Fan, Hua Zhang, ZengLei Zhang, ZhaoCai Liu, YeCheng Zhou, XianLiang Zhu, HuaDong Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors, most of which are characterized by the release of catecholamine, and range in diameters from less than 1 cm to 10 cm or more. However, knowledge of the differences in clinical features between small and large PPGLs is insufficient. METHODS: A retrospective analysis of patients with PPGLs treated at our institution between January 2018 and June 2020 was performed. The clinical characteristics of patients were investigated, and comparisons were made between patients with large and small PPGLs. The logistic regression analysis was used to confirm the risk factors, and the receiver operating characteristic curve was used to evaluate the diagnostic performance of the variables. RESULTS: Totally 263 patients were included, including 110 patients in small tumor group and 153 patients in large tumor group. There were more male patients in the large tumor group (p=0.009). More patients had hypertension (p<0.001) and diabetes (p=0.002) in the large tumor group. The 24-h urinary epinephrine (24hU-E) (p < 0.001) and 24-h urinary norepinephrine (24hU-NE) (p=0.002) concentrations were higher in the large tumor group. In terms of tumor location, adrenal-PPGLs were more frequent in the large tumor group (p<0.001). Multivariate logistic regression analysis showed that male sex [odds ratio (OR): 2.871, 95% confidence interval (CI): 1.444–5.711, p=0.003], 24hU-E concentrations (OR: 1.025, 95% CI:1.004–1.047, p=0.020), 24hU-NE concentrations (OR: 1.002, 95%CI: 1.001–1.004, p=0.045), and adrenal-PPGLs (OR: 2.510, 95% CI:1.256–5.018, p=0.009) were positive risk factors for large tumors. Taking above variables into the same model, the area under the receiver operating characteristic curve of the model for predicting the large tumor was 0.772 (95% CI: 0.706–0.834). After the short-term follow-up, there was no significant difference in tumor recurrence between the two groups (p=0.681). CONCLUSIONS: Significant differences in numerous clinical characteristics exist between large and small PPGLs. The male patients were more likely to be with large tumors, and such tumors were more likely to reside on the adrenal glands. Catecholamine measurements also help predict tumor size of PPGLs. Clinical decision-making will benefit from this information. Frontiers Media S.A. 2023-03-09 /pmc/articles/PMC10034061/ /pubmed/36967797 http://dx.doi.org/10.3389/fendo.2023.1087506 Text en Copyright © 2023 Zhao, Li, Meng, Fan, Zhang, Zhang, Liu, Zhou and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhao, Lin
Li, ZhiMao
Meng, Xu
Fan, Hua
Zhang, ZengLei
Zhang, ZhaoCai
Liu, YeCheng
Zhou, XianLiang
Zhu, HuaDong
Clinical differences between small and large pheochromocytomas and paragangliomas
title Clinical differences between small and large pheochromocytomas and paragangliomas
title_full Clinical differences between small and large pheochromocytomas and paragangliomas
title_fullStr Clinical differences between small and large pheochromocytomas and paragangliomas
title_full_unstemmed Clinical differences between small and large pheochromocytomas and paragangliomas
title_short Clinical differences between small and large pheochromocytomas and paragangliomas
title_sort clinical differences between small and large pheochromocytomas and paragangliomas
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034061/
https://www.ncbi.nlm.nih.gov/pubmed/36967797
http://dx.doi.org/10.3389/fendo.2023.1087506
work_keys_str_mv AT zhaolin clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT lizhimao clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT mengxu clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT fanhua clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT zhangzenglei clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT zhangzhaocai clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT liuyecheng clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT zhouxianliang clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas
AT zhuhuadong clinicaldifferencesbetweensmallandlargepheochromocytomasandparagangliomas